LEXARIA BIOSCIENCE CORP. Cash and Cash Equivalents
LEXARIA BIOSCIENCE CORP. (LEXX) had Cash and Cash Equivalents of $3.50 million as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-13
- 2026-05-31: Cash and Cash Equivalents, at Carrying Value $3.50M.
- 2026-02-28: Cash and Cash Equivalents, at Carrying Value $5.10M.
- 2025-11-30: Cash and Cash Equivalents, at Carrying Value $4.30M.
- 2025-05-31: Cash and Cash Equivalents, at Carrying Value $4.60M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-05-31 | $3.50M 10-Q · filed 2026-07-13 | |
| 2026-02-28 | $5.10M 10-Q · filed 2026-04-13 | |
| 2025-11-30 | $4.30M 10-Q · filed 2026-01-13 | |
| 2025-05-31 | $4.60M 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $6.50M 10-Q · filed 2025-04-14 | |
| 2023-02-28 | $3.27M 10-Q · filed 2023-04-14 | |
| 2022-11-30 | $4.53M 10-Q/A · filed 2023-01-18 | |
| 2022-08-31 | $5.81M 10-Q · filed 2023-04-14 | |
| 2022-05-31 | $7.05M 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $8.36M 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $9.68M 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $10.92M 10-K · filed 2022-11-28 | |
| 2021-05-31 | $8.11M 10-Q · filed 2022-07-14 | |
| 2021-02-28 | $9.35M 10-Q · filed 2022-04-11 | |
| 2020-11-30 | $525.34K 10-Q · filed 2022-01-14 | |
| 2020-08-31 | $1.29M 10-Q · filed 2022-07-14 | |
| 2020-05-31 | $2.03M 10-Q · filed 2021-07-15 | |
| 2020-02-29 | $739.99K 10-Q · filed 2021-04-14 | |
| 2019-11-30 | $1.33M 10-Q · filed 2021-01-14 | |
| 2019-08-31 | $1.29M 10-K · filed 2021-11-29 | |
| 2019-05-31 | $2.00M 10-Q · filed 2019-07-08 | |
| 2019-02-28 | $2.00M 10-Q · filed 2020-06-29 | $3.09M 10-Q · filed 2019-04-15 |
| 2018-11-30 | $2.64M 10-Q · filed 2020-01-09 | |
| 2018-08-31 | $1.73M 10-K · filed 2020-10-15 | |
| 2018-05-31 | $2.06M 10-Q · filed 2019-07-08 | |
| 2018-02-28 | $2.32M 10-Q · filed 2019-04-15 | |
| 2017-11-30 | $2.21M 10-Q · filed 2019-01-11 | |
| 2017-08-31 | $2.53M 10-K · filed 2019-11-14 | |
| 2017-05-31 | $2.79M 10-Q · filed 2018-07-13 | |
| 2017-02-28 | $523.63K 10-Q · filed 2018-04-12 | |
| 2016-11-30 | $124.25K 10-Q · filed 2018-01-12 | |
| 2016-08-31 | $93.41K 10-K · filed 2018-11-14 | |
| 2016-08-28 | $93.41K 10-Q · filed 2017-04-14 | |
| 2016-05-31 | $37.10K 10-Q · filed 2017-07-14 | |
| 2016-02-29 | $40.22K 10-Q · filed 2017-04-14 | |
| 2015-11-30 | $84.03K 10-Q · filed 2017-01-13 | |
| 2015-08-31 | $260.07K 10-K · filed 2018-11-14 | |
| 2015-08-29 | $260.07K 10-Q · filed 2017-04-14 | |
| 2015-05-31 | $832.10K 10-Q · filed 2016-07-13 | |
| 2015-02-28 | $792.02K 10-Q · filed 2016-04-13 | $792.02K 10-Q · filed 2015-04-14 |
| 2014-11-30 | $431.07K 10-Q · filed 2016-01-08 | |
| 2014-08-31 | $703.03K 10-K · filed 2016-11-29 | |
| 2014-08-28 | $703.03K 10-Q · filed 2016-04-13 | |
| 2014-07-31 | $578.48K 10-Q · filed 2014-11-14 | |
| 2014-05-31 | $877.89K 10-Q · filed 2015-07-14 | |
| 2014-04-30 | $951.74K 10-Q · filed 2014-06-12 | |
| 2014-02-28 | $36.90K 10-Q · filed 2015-04-14 | |
| 2014-01-31 | $28.66K 10-Q · filed 2014-03-12 | |
| 2013-11-30 | $125.19K 10-Q · filed 2015-01-14 | |
| 2013-10-31 | $65.54K 10-KT · filed 2014-12-09 | |
| 2013-08-31 | $65.54K 10-K · filed 2015-11-27 | $38.91K 10-KT · filed 2014-12-09 |
| 2013-08-28 | $65.54K 10-Q · filed 2015-04-14 | |
| 2013-07-31 | $27.53K 10-Q · filed 2014-11-14 | |
| 2013-04-30 | $44.53K 10-Q · filed 2014-06-12 | |
| 2013-01-31 | $38.94K 10-Q · filed 2014-03-12 | |
| 2012-10-31 | $180.51K 10-KT · filed 2014-12-09 | |
| 2012-07-31 | $16.45K 10-Q · filed 2013-09-10 | |
| 2012-04-30 | $120.56K 10-Q · filed 2013-06-12 | |
| 2012-01-31 | $140.48K 10-Q · filed 2013-03-13 | |
| 2011-10-31 | $31.20K 10-K · filed 2014-01-24 | |
| 2011-07-31 | $494.44K 10-Q · filed 2012-09-12 | |
| 2011-04-30 | $126.84K 10-Q · filed 2012-06-07 | |
| 2011-01-31 | $279.60K 10-Q · filed 2012-03-13 | |
| 2010-10-31 | $62.99K 10-K · filed 2013-01-29 | |
| 2010-07-31 | $431.39K 10-Q · filed 2011-09-14 | |
| 2009-10-31 | $330.17K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |